《风湿症杂志》.2005年.第1期

......

• Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
• Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden system
• When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
• Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index
• Assessing competencies in rheumatology
• A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients w
• A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
• Is rheumatoid arthritis disappearing?
• Incidence and prevalence of complaints of the neck and upper extremity in general practice
• Prevalence and predictors of fragility fractures in systemic lupus erythematosus
• Patient centred outcomes in osteoarthritis
• Pain and joint mobility explain individual subdimensions of the health assessment questionnaire(HAQ) disability index in patients with rheu
• Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj?gren’s syndrome
• Prevalence and determinants of one month hand pain and hand related disability in the elderly(Rotterdam study)
• Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale
• Capability for daily activities in old people with rheumatoid arthritis: a population based study
• Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis
• Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout
• Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis
• Case number 32: Thiemann’s disease
• First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing ad
• Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important impr
• Defining hip pain for population studies
• Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium
• A good response to early DMARD treatment of patien
• Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden system
• Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj?gren’s syndrome
• Prevalence and determinants of one month hand pain and hand related disability in the elderly(Rotterdam study)
• Prevalence and predictors of fragility fractures in systemic lupus erythematosus
• When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
• Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index
• Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale
• Association between baseline radiographic damage a
• Assessing competencies in rheumatology
• A multicentre, randomised, double blind, placebo c
• Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important impr
• Defining hip pain for population studies
• Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout
• Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis
• Case number 32: Thiemann’s disease
• Capability for daily activities in old people with rheumatoid arthritis: a population based study
• Patient centred outcomes in osteoarthritis
• Pain and joint mobility explain individual subdimensions of the health assessment questionnaire(HAQ) disability index in patients with rheu
• Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium
• Is rheumatoid arthritis disappearing?
• Incidence and prevalence of complaints of the neck and upper extremity in general practice
• First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing ad
• Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis